Pelthos Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 66.3% | 66.3% | -4,464.2% |
| FY2023 | 114.5% | 114.5% | -7,657.1% |
| FY2024 | 293.1% | 293.1% | -581.1% |
| FY2025 | -111.4% | -111.4% | -33.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 66.3% | 66.3% | -4,464.2% |
| FY2023 | 114.5% | 114.5% | -7,657.1% |
| FY2024 | 293.1% | 293.1% | -581.1% |
| FY2025 | -111.4% | -111.4% | -33.2% |